Cargando…

A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer

SIMPLE SUMMARY: Moderate hypofractionated radiotherapy (HF) has become the standard fractionation scheme for most breast cancer patients. Despite comprehensive data from large, randomized trials, standardized assessment of patient reported outcome (PRO) and physiological changes after HF are largely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borm, Kai J., Kleine Vennekate, Johanne, Vagedes, Jan, Islam, Mohammad O. A., Duma, Marciana N., Loos, Maximilian, Combs, Stephanie E., Schiller, Kilian, Klusen, Sophie, Paepke, Stefan, Kiechle, Marion B., Paepke, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616262/ https://www.ncbi.nlm.nih.gov/pubmed/34830981 http://dx.doi.org/10.3390/cancers13225826

Ejemplares similares

Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors
por: Borm, Kai J., et al.
Publicado: (2018)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer
por: Borm, Kai J., et al.
Publicado: (2020)

Effectiveness of hypofractionated and normofractionated radiotherapy in a triple‐negative breast cancer model
por: Grosche, Sinja, et al.
Publicado: (2022)

Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy
por: Drozdoff, Loisa, et al.
Publicado: (2018)

Simultaneous integrated boost within the lymphatic drainage system in breast cancer: A single center study on toxicity and oncologic outcome
por: Klusen, Sophie T., et al.
Publicado: (2023)

Demand for integrative medicine among women in pregnancy and childbed: a German survey on patients’ needs
por: Schürger, Nikolas, et al.
Publicado: (2018)

Evaluation of an Expert Guided Integrative Therapy Concept in Patients With Breast or Gynecological Cancer During Systemic Therapy
por: Schmidt, Georg, et al.
Publicado: (2020)

Lifestyle modifications after the diagnosis of gynecological cancer
por: Paepke, Daniela, et al.
Publicado: (2021)

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer
por: Nakajima, Koichiro, et al.
Publicado: (2022)

Potential Interactions of Biologically Based Complementary Medicine in Gynecological Oncology
por: Drozdoff, Loisa, et al.
Publicado: (2019)

Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3)
por: Sarria, Gustavo R., et al.
Publicado: (2022)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Alfredo, Conti, et al.
Publicado: (2019)

Neuroanatomical changes seen in MRI in patients with cerebral metastasized breast cancer after radiotherapy
por: Reibelt, Antonia, et al.
Publicado: (2021)

Correction to: Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Conti, Alfredo, et al.
Publicado: (2020)

First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer
por: Ettl, Johannes, et al.
Publicado: (2020)

An easy way to determine bone mineral density and predict pelvic insufficiency fractures in patients treated with radiotherapy for cervical cancer
por: Kurrumeli, Drilon, et al.
Publicado: (2020)

Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries
por: Duma, Marciana Nona, et al.
Publicado: (2017)

Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis
por: Issoufaly, Irfane, et al.
Publicado: (2022)

Moving targets in 4D-CTs versus MIP and AIP: comparison of patients data to phantom data
por: Borm, Kai Joachim, et al.
Publicado: (2018)

Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany
por: Grimm, Donata, et al.
Publicado: (2020)

Deep inspiration breath-hold for left-sided breast irradiation: Analysis of dose-mass histograms and the impact of lung expansion
por: Oechsner, Markus, et al.
Publicado: (2019)

Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1
por: Ettl, Johannes, et al.
Publicado: (2017)

Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients?
por: Münch, Stefan, et al.
Publicado: (2017)

Surgical Studies of Reconstructive Breast Surgery – An Overview of the Topics at the 2019 Annual Meeting of the Working Group for Reconstructive Surgery in Oncology-Gynecology
por: Paepke, Stefan, et al.
Publicado: (2019)

Tangential Field Radiotherapy for Breast Cancer—The Dose to the Heart and Heart Subvolumes: What Structures Must Be Contoured in Future Clinical Trials?
por: Duma, Marciana Nona, et al.
Publicado: (2017)

Pregnancy following Unilateral Immediate Breast Reconstruction with Titanized Polypropylene Mesh (TiLOOP(R) Bra) without Compromising the Result
por: Nolte, Elke, et al.
Publicado: (2018)

Quality of Life in Breast Cancer Patients Treated With Mistletoe Extracts: A Systematic Review and Meta-Analysis
por: Loef, Martin, et al.
Publicado: (2023)

Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward
por: Krug, David, et al.
Publicado: (2021)

Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting
por: Devecka, Michal, et al.
Publicado: (2020)

MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease
por: Mayinger, Michael, et al.
Publicado: (2019)

The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges
por: Aubele, Michaela, et al.
Publicado: (2017)

Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines
por: Schatz, Julia, et al.
Publicado: (2022)

Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy - is it time to adjust current contouring guidelines to the radiation technique?
por: Mayinger, Michael, et al.
Publicado: (2019)

Outcomes of immediate oncoplastic surgery and adjuvant radiotherapy in breast cancer patients
por: Borm, Kai Joachim, et al.
Publicado: (2019)

Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer
por: Borm, Kai J., et al.
Publicado: (2022)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
por: Klement, Rainer J., et al.
Publicado: (2021)

As Easy as 1, 2, 3? How to Determine CBCT Frequency in Adjuvant Breast Radiotherapy
por: Junker, Yannis, et al.
Publicado: (2022)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
por: Habl, Gregor, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o2kqbu1ptu2c7b4n0v9dbhvt67